Venlafaxine Hydrochloride
Product Images NDC 50090-5748

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-5748). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500905748)

Venlafaxine hydrochloride 37.5 mg extended release capsules packaging label from A-S Medication Solutions. The label includes the product NDC 50090-5748-0, dosage strength (37.5 mg), and storage instructions to keep the capsules at 45 to 70 degrees F. The packaging contains 30 capsules in a bottle.*

FDA Label Image

Fig-1 (Venlafaxine Fig 1)

A pharmacokinetic (PK) fold change chart showing the effects of various interacting drugs on venlafaxine and its analytes using measures like Cmax and AUC. The graph displays relative changes with 90% confidence intervals and recommendations for concomitant use or dose adjustments for drugs such as ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium.*

FDA Label Image

Fig-2 (Venlafaxine Fig 2)

A pharmacokinetic chart depicting the fold change in Cmax and AUC values for various interacting drugs with Venlafaxine hydrochloride. The horizontal axis shows change relative to a reference value, with a vertical line at 1 indicating no change. Each drug and analyte pair is plotted with error bars, alongside recommendations such as avoid use, no dose adjustment, use with caution, and clinical significance unknown.*

FDA Label Image

Fig-3 (Venlafaxine Fig 3)

A figure showing fold change with 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of venlafaxine and its metabolite ODV across various special populations including hepatic and renal impairment, CYP2D6 polymorphisms, age, and gender. The chart compares these changes relative to a reference value and includes dosing recommendations based on these changes.*

FDA Label Image

Str (Venlafaxine Str)

Chemical structure of venlafaxine hydrochloride displaying the molecular formula with a cyclohexanol group, methoxyphenyl group, and dimethylaminoethyl side chain, labeled along with the HCl component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.